GGrantIndex
Sort

64,565 grants matching drug discovery

Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV

$626,362
Stefan G Sarafianos · Emory University · R37 · FY2025 · AI

MWAS+ – A Novel Drug Repurposing Strategy for ADRD Prevention

$626,355
Qing Zeng · George Washington University · R01 · FY2025 · AG

African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation

$626,351
Minoli A Perera · Northwestern University At Chicago · U54 · FY2020 · MD

Targeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferi

$626,225
Xiaofeng Frank Yang · Indiana University Indianapolis · R01 · FY2021 · AI

Molecular identity of exosomal BK channels

$626,209
Harpreet Singh · Ohio State University · R01 · FY2022 · HL

Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease

$626,121
Marialena Mouzaki · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · DK

5/7 Psychiatric Genomics Consortium: Finding actionable variation

$626,109
Michael O'Donovan · Cardiff University · U01 · FY2016 · MH

Elucidating Protective Mechanisms for Cardiotoxicity of Kinase Inhibitors

$626,062
Mark Mercola · Stanford University · P01 · FY2024 · HL

Collaborative Research: Direction and Mechanisms of Seasonal Change in Arctic Microbial Communities

$626,054
Karen E Nelson · J. Craig Venter Institute, Inc. · · FY2012 · GEO

Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder

$625,964
Dana B Hancock · Research Triangle Institute · R01 · FY2019 · AA

Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis

$625,937
Leah Elizabeth Cowen · University Of Toronto · R01 · FY2022 · AI

Electrophysiological Endophenotypes of Schizophrenia in Mouse and Man

$625,924
Margaret Levin · Galenea Corporation · R01 · FY2012 · MH

Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators

$625,914
Shana O Kelley · Northwestern University · R01 · FY2023 · CA

Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators

$625,914
Shana O Kelley · Northwestern University · R01 · FY2025 · CA

Developing novel inhibitors of the gut microbiome to modulate drug metabolism

$625,834
Bret David Wallace · Symberix, Inc. · R44 · FY2020 · TR

Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting

$625,818
Donald M Coen · Harvard Medical School · R01 · FY2010 · AI

Validation and characterization of the identified variants associated with human longevity in mouse models

$625,780
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2024 · AG

PET ligand development for mGlu2 based on negative allosteric modulators

$625,674
Steven H Liang · Massachusetts General Hospital · R01 · FY2020 · MH

Functional maturation of amygdala circuitry during adolescence

$625,634
Joshua G Corbin · Children'S Research Institute · R56 · FY2025 · MH

Quantitative Structural and Functional Imaging of the Lung

$625,547
Rahim R Rizi · University Of Pennsylvania · R01 · FY2009 · HL

WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE

$625,517
Kooresh Isaac Shoghi · Washington University · U24 · FY2020 · CA

A dual-acting small molecule for the treatment of type 1 diabetes

$625,501
Shiyong Wu · Asake Biotechnology, Llc · R42 · FY2025 · DK

CAREER: Effectuating Hardware-Accelerated Systems with Domain-Specific Primitives

$625,448
Lisa W Wills · Duke University · · FY2021 · CSE

Pharmacology of intrathecal/intraventricular polymyxins: A systems-based approach

$625,436
Gauri G Rao · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI

Enabling new translational discoveries using a genomic data-driven nosology

$625,423
Atul J Butte · Stanford University · R01 · FY2012 · GM